par Agathe Masson | Juin 26, 2025 | Access to Care, NCD Partnerships, Actualités
In many low- and middle-income countries (LMICs), a childhood cancer diagnosis often comes with limited access to timely treatment, essential medicines, and consistent care. That’s why earlier this year, NCDconnect—through IDA Foundation—joined the Access Cancer...
par Agathe Masson | Mai 15, 2025 | Healthcare Systems, NCD Policy, Actualités
World Hypertension Day 2025 | Theme: “Measure Your Blood Pressure Accurately, Control It, Live Longer” High blood pressure (hypertension) remains one of the leading risk factors for cardiovascular disease and premature death worldwide. Yet in many low- and...
par Agathe Masson | Déc 17, 2024 | NCD Case Studies, NCD Partnerships, Actualités
Following the agreement on a new licensing model between the Medicines Patent Pool (MPP) & Novartis in collaboration with the ATOM Coalition, generic, quality-assured nilotinib is now available on NCDconnect! This initiative is crucial in making lifesaving...
par Agathe Masson | Déc 9, 2024 | Access to Care, NCD Solutions, Actualités
Sickle Cell Disease (SCD) is a genetic blood disorder that affects millions of people worldwide. Between 2010 and 2050, an estimated 14 million babies will be affected globally, with the vast majority born in low- and middle-income countries (LMICs). This staggering...
par Agathe Masson | Nov 19, 2024 | Healthcare Systems, NCD Policy, Actualités
“Localisation.” It’s a term we’ve heard frequently in recent years, but not without its critics—and perhaps rightly so. Many argue that “localisation” doesn’t fully capture the essence of legitimising communities to lead their own health solutions, often implying a...
